Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Oxis International completes phase I testing of IBD treatment

Jan. 8, 1997

Anti-HCV agents revealed by Japanese and Chinese investigators

Jan. 8, 1997

Prokinetic agents from Tokyo Tanabe

Jan. 8, 1997

Shin Nippon discloses antiulcer agents

Jan. 7, 1997

Lansoprazole equieffective to omeprazole in Dutch trial

Jan. 2, 1997

Novel human serine protease inhibitor for pancreatitis claimed by Incyte

Jan. 2, 1997

Additional filings and positive clinical results for Zadaxin

Dec. 23, 1996

Takeda claims new treatments for pancreatitis

Dec. 23, 1996

Novel 5-HT4 receptor agonist claimed by Pharmacia & Upjohn

Dec. 13, 1996

Roberts in-licenses another GI drug from Lilly

Dec. 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...